2026 NPPES data Hematology & Oncology Physician NPI 1750358487 MD
Verify on CMS →

IRVING LAFRANCIS, MD

Hematology & Oncology Physician in JOPLIN, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 250 beneficiaries · Hematology & Oncology Physician avg: 847
Industry payments
$119.61
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: IRVING LAFRANCIS, MD is a Hematology & Oncology Physician ([object Object]) practicing in JOPLIN, Missouri with a Medicare Part D prescribing footprint of 1K claims across 250 beneficiaries . Industry payments of $119.61 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: IRVING LAFRANCIS, MD filed 1,370 Medicare Part D claims in 2023 across JOPLIN, Missouri. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

IRVING LAFRANCIS, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

IRVING LAFRANCIS, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/01/2006

NPI 1750358487

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,370 62% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Missouri

How Hematology & Oncology Physician compares to other specialties among Missouri providers

Missouri providers

Hematology & Oncology Physician share within Missouri

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

IRVING LAFRANCIS, MD is a Hematology & Oncology Physician provider practicing in JOPLIN, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1750358487. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

IRVING LAFRANCIS, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 100 MERCY WAY, JOPLIN, MO, 64804, with a listed phone of (417) 782-7722. NPI 1750358487 was issued on 03/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LAFRANCIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,370 prescription claims written by this provider, covering 250 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, with an opioid prescribing rate of 18.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 MERCY WAY
JOPLIN, MO 64804

Provider Details

NPI 1750358487
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 03/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for IRVING LAFRANCIS, MD. Source: openpaymentsdata.cms.gov.

Total received

$120

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,370
Total Claims
$2.2M
Total Drug Cost
250
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,010
Total Day Supply
52,902
Generic Drug Cost
$410K
Opioid Claims
248 (18.1% rate)
Antibiotic Claims
16

Patient Demographics

Average Patient Age
71.5 years
Avg HCC Risk Score
2.39
Gender Split
62% female / 38% male
Age Distribution
<65: 42, 65-74: 117, 75-84: 72, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamoxifen Citrate
176
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
103
Anastrozole
86
Warfarin Sodium
79
Letrozole
72
Ondansetron Odt
Ondansetron
48
Tramadol Hcl
44
Abiraterone Acetate
42
Prednisone
39
Gabapentin
36

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How IRVING LAFRANCIS, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

IRVING LAFRANCIS, MD's 1,370 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as LAFRANCIS.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is IRVING LAFRANCIS, MD's specialty?
IRVING LAFRANCIS, MD specializes in Hematology & Oncology Physician and practices in JOPLIN, Missouri. Credentials: MD.
How much does IRVING LAFRANCIS, MD prescribe under Medicare Part D?
In 2023, IRVING LAFRANCIS, MD wrote 1,370 Medicare Part D claims totaling $2.2M in drug costs for 250 beneficiaries.
Where is IRVING LAFRANCIS, MD located?
IRVING LAFRANCIS, MD is located at 100 MERCY WAY, JOPLIN, MO, 64804. Phone: (417) 782-7722.
What is IRVING LAFRANCIS, MD's NPI number?
IRVING LAFRANCIS, MD's National Provider Identifier (NPI) is 1750358487, issued on 03/01/2006.
Does IRVING LAFRANCIS, MD prescribe opioids?
Yes, IRVING LAFRANCIS, MD had 248 opioid claims in 2023 with an opioid prescribing rate of 18.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does IRVING LAFRANCIS, MD prescribe most often?
Based on 2023 Medicare Part D data, IRVING LAFRANCIS, MD's most frequently prescribed drugs include Tamoxifen Citrate, Hydrocodone-Acetaminophen, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does IRVING LAFRANCIS, MD accept Medicare?
IRVING LAFRANCIS, MD appears in CMS Medicare data with 1,370 Part D claims and 250 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify IRVING LAFRANCIS, MD's credentials?
IRVING LAFRANCIS, MD's NPI is 1750358487 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology